
Keywords: استروما واکنشی; AR; androgen receptor; ARPI; androgen receptor pathway inhibition; CRPC; castrate-resistant prostate cancer; PCa; prostate cancer; BPH; benign prostate hyperplasia; ERα; estrogen receptor-α; PR; progesterone receptor; PRA; PR isoform A; PRB; PRB isoform